Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Divi Cornec

Showing results (191-200 of 197) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 197 results.
Rheumatology (Oxford, England)|December 19, 2024
Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional studyAlice Tison, Sandrine Jousse-Joulin, Maëlys Consigny, et al.
Nature Communications|June 11, 2021
A new molecular classification to drive precision treatment strategies in primary Sjögren's syndromePerrine Soret, Christelle Le Dantec, Emiko Desvaux, et al.
Annals of the Rheumatic Diseases|June 17, 2025
Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)Simon J Bowman, Raphaele Seror, Raphael Porcher, et al.
RMD Open|November 1, 2022
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)Jacques-Eric Gottenberg, Aurore Chaudier, Yves Allenbach, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 6, 2019
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort StudyAlice Tison, Gilles Quéré, Laurent Misery, et al.
Seminars in Arthritis and Rheumatism|February 4, 2024
The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generationRachael A Gordon, Yann Nguyen, Nathan Foulquier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2021
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune DiseasesGuillermo Barturen, Sepideh Babaei, Francesc Català-Moll, et al.
Pageof 20

Showing results (191-200 of 197) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 197 results.
Rheumatology (Oxford, England)|December 19, 2024
Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional studyAlice Tison, Sandrine Jousse-Joulin, Maëlys Consigny, et al.
Nature Communications|June 11, 2021
A new molecular classification to drive precision treatment strategies in primary Sjögren's syndromePerrine Soret, Christelle Le Dantec, Emiko Desvaux, et al.
Annals of the Rheumatic Diseases|June 17, 2025
Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)Simon J Bowman, Raphaele Seror, Raphael Porcher, et al.
RMD Open|November 1, 2022
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)Jacques-Eric Gottenberg, Aurore Chaudier, Yves Allenbach, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 6, 2019
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort StudyAlice Tison, Gilles Quéré, Laurent Misery, et al.
Seminars in Arthritis and Rheumatism|February 4, 2024
The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generationRachael A Gordon, Yann Nguyen, Nathan Foulquier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2021
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune DiseasesGuillermo Barturen, Sepideh Babaei, Francesc Català-Moll, et al.
Pageof 20